Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b+HLA-A24+patients-Reference-Cited by-同舟云学术

Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b+HLA-A24+patients

Published:2007-03 Issue:3 Volume:37 Page:186-195
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Takao Yukari,Yamada Akira,Yutani Shigeru,Takedatsu Hiroko,Ono Takeharu,Etoh Kojyu,Wang Yi,Suzuki Susumu,Ide Tatsuya,Shimotohno Kunitada,Sata Michio,Itoh Kyogo

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1872-034X.2007.00018.x/fullpdf

Reference25 articles.

1. Treatment of chronic hepatitis C: A systematic review

2. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.

3. Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States

4. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Response of Cytotoxic T Lymphocytes and Possibility of Vaccine Development for Hepatitis C Virus Infection;Journal of Biomedicine and Biotechnology;2010

2. Detection of IgE Antibody Specific to a Hepatitis C Virus–Derived Peptide Being Recognized by Cellular Immunity in Patients with HCV Infection;Viral Immunology;2008-09

3. Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy;Vaccine;2007-10